Overview
Binds to VEGFR2 and FAK pathways in injured tissues.
Proposed mechanism
BPC-157 stimulates growth factor receptors and angiogenesis pathways, accelerating tissue repair at injury sites.
What the evidence supports
Human data exists but the trials are small, short-term, or not yet replicated.
Graded Human-limited
Human data that exists but is thin: open-label work, single-arm studies, small cohorts, or observational follow-up without randomisation.
Key citations
Representative primary sources, including results that did not favour the compound.
- [1]
BPC-157 in tendon healing
· DOI:10.1177/0363546515605371 · 2015
- [2]
BPC-157 in tendon healing (2015)
· · 0
Citation records in this build are illustrative placeholders for the design.
Reference information for research purposes. Not medical advice, and not a recommendation to use any compound. Many entries describe substances that are not approved for human use.